当前位置: 首页 > 医疗版 > 疾病专题 > 心血管科 > 下肢深静脉血栓
编号:13310012
消肿止痛液治疗具有出血风险的深静脉血栓治疗效果的探讨(2)
http://www.100md.com 2018年4月1日 《健康大视野》 2018年第7期
     参考文献

    [1]Qian K , Xu J , Wan H ,et al.Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis [J].Gene,2015 ,569 (2): 173-181

    [2]Praeger AJ,Westbrook AJ,Nichol AD,et al.Deep vein throm-bosis and pulmonary embolus in patients with traumatic brain injury:a prospective observational study[J].Crit Care Resusc,2012,14(1):10-13

    [3]Ciuti G,Grifoni E,Pavellini A.Pavellini AIncidence and char-acteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting [J].Thromb Res,2012,11(14):231-234

    [4]Kearon C,Kahn SR,Agnelli G,et al.Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):454-455

    [5]繆建春, 蔡威黔,卢素琳.消肿止痛液的药效学研究[J].国初级卫生保健,2005 , 19 (11 ):79-80

    [6]崔桂萍 , 郭海枫 , 薛凯 .急性颅脑损伤后部分凝血指标变化的研究[J].检验医学,2007,22( 2):185-187, 百拇医药(郑永恒 王纪臣 张学慧 王晓军)
上一页1 2


    参见:首页 > 医疗版 > 疾病专题 > 心血管科 > 下肢深静脉血栓